Addition of Ipilimumab to Dacarbazine Improves Survival in Metastatic Melanoma - ONA
Links shared publicly online about this topic.
- 240total visits
Addition of Ipilimumab to Dacarbazine Improves Survival in Metastatic Melanoma - ONA
Ipilimumab in combination with dacarbazine significantly improved overall survival (OS) in metastatic melanoma compared with dacarabazine alone, according to data presented at the American Society of Clinical Oncology’s 2011 Annual Meeting.
View full resource at oncologynurseadvisor.com
Tags: Cancer, Skin Cancer, Melanoma
Most Recently Shared on June 5, 2011 at 10:11 pm By:
Addition of Ipilimumab to Dacarbazine Improves Survival in Metastatic Melanoma http://goo.gl/fb/MMbg2
Addition of Ipilimumab to Dacarbazine Improves Survival in Metastatic Melanoma - MPR
empr.com — “Ipilimumab in combination with dacarbazine significantly improved overall survival (OS) in metastatic melanoma compared with dacarabazine alone, according to data presented at the American Society of Clinical Oncology’s 2011 Annual Meeting.” View full resource at empr.com
Most Recently Shared on June 5, 2011 at 9:59 pm By:
#asco2011 Addition of Ipilimumab to Dacarbazine Improves Survival in Metastatic Melanoma http://goo.gl/fb/PW8fN
Advertisement
